Ad is loading...
DGECX
Price
$19.50
Change
-$0.18 (-0.91%)
Updated
Nov 15 closing price
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DGECX vs FNWFX

Header iconDGECX vs FNWFX Comparison
Open Charts DGECX vs FNWFXBanner chart's image
BNY Mellon Global Emerging Mkts - C
Price$19.50
Change-$0.18 (-0.91%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DGECX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGECX vs. FNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGECX is a Buy and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. DGECX (395M). FNWFX pays higher dividends than DGECX: FNWFX (1.56) vs DGECX (0.00). DGECX was incepted earlier than FNWFX: DGECX (11 years) vs FNWFX (8 years). DGECX is a more actively managed with annual turnover of: 44.72 vs. FNWFX (32.00). DGECX has a lower initial minimum investment than FNWFX: DGECX (1000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 11.59 vs. DGECX (7.79). DGECX return over 5 years is better than : 25.45 vs. FNWFX (17.23).
DGECXFNWFXDGECX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years8 years-
Gain YTD3.0667.14743%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets395M60.9B1%
Annual Yield % from dividends0.001.56-
Returns for 1 year7.7911.5967%
Returns for 3 years-27.94-14.49193%
Returns for 5 years25.4517.23148%
Returns for 10 years32.76N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology